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Abstract Matrix-assisted laser desorption/ionization mass 
spectrometry (MALDI-MS) has been used for C-terminal amino 
acid sequence determination of peptides and proteins. The useful- 
ness of MALDI-MS was demonstrated by analyzing peptide mix- 
tures (C-terminal peptide ladder) which were generated by enzy- 
matic digestion of substance P, glucagon, angiotensinogen, i sulin 
B chain and myoglobin with the exopeptidases carboxypeptidase 
Y and P. The results clearly show that up to 11 amino acid 
residues can be determined in the pmol range by analyzing the 
molecular masses of the truncated peptides. For proteins it is 
possible to investigate nzymatic or chemical digests in the same 
manner. 
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I. Introduction 
In recent years, matrix-assisted UV laser desorption/ioniza- 
tion mass spectrometry (MALDI-MS), introduced by Karas 
and Hillenkamp [1], has become a useful tool to determine the 
molecular mass of biomolecules. Applications of MALDI-MS 
for analysis of proteins [2], glycoproteins [3], oligosaccharides 
[4], and oligonucleotides [5,6] have been reported. Because of 
the sensitivity in the pmol range and the tolerance toward many 
buffer systems, MALDI-MS is a suitable technique for analysis 
of peptide mixtures resulting from enzymatic protein digestion 
[7]. A new approach to N-terminal protein sequencing that 
combines multiple steps of Edman degradation chemistry with 
a MALDI-MS determination f the concatenated set of peptide 
fragments was described as 'protein ladder sequencing' [8]. 
However, the method is limited to the N-terminus of peptides 
or proteins and requires the formation of stable phenylcar- 
bamyl peptides. 
Sequence information from the C-terminus of proteins is 
especially of interest in the investigation of N-terminal blocked 
peptides and proteins and for confirmation of DNA sequence 
data and cloning experiments. Chemical methods for C-termi- 
nal sequencing have been developed, but no method for the 
C-terminal sequence analysis has yet been described which 
works satisfactorily in cases of all amino acids [9-11], compara- 
ble with Edman degradation for the N-terminal region [12]. 
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Abbreviations." MALDI-MS, matrix assisted laser desorption/ioniza- 
tion mass spectrometry; LC-MS, liquid chromatography mass spec- 
trometry; CPY, carboxypeptidase Y; CPP, carboxypeptidase P; TFA, 
trifluoroacetic acid; Da, Dalton. 
Besides chemical modification, carboxypeptidases have fre- 
quently been used for C-terminal sequencing [13], either by 
determining the release of free amino acids or by identifying the 
truncated peptides by mass spectrometry. To analyse C-termi- 
nally truncated peptides, fast atom bombardment (FAB-MS) 
[14-16], plasma desorption mass spectrometry (PDMS) [17], 
thermospray LC-MS [18,19] and electrospray ionization [20] 
have been used for monitoring carboxypeptidase digestions. 
The kinetics for the enzymatic release of different amino 
acids varies considerably. Therefore, the amino acid analysis is 
very complex and misinterpretations due to internal cleavages 
of the polypeptide chain and/or the release of dipeptides may 
occur. Although carboxypeptidase Y (CPY) releases all C-ter- 
minal amino acids from peptides or proteins, including Pro [13], 
in some cases the reaction conditions are not sufficient o ob- 
tain an interpretable s quential release of amino acids [21]. To 
overcome these problems and to obtain additional information 
we used carboxypeptidase Y (slow release of Gly and Asp) and 
P (slow release of Ser and Gly) to generate C-terminal truncated 
peptides ('C-terminal peptide ladder') since CPP can supple- 
ment CPY in releasing all amino acids. In the present work we 
study the combination of carboxypeptidase digestion with 
monitoring of the C-terminal peptide ladder by the fast and 
sensitive MALDI-MS technique. 
2. Materials and methods 
2.1. Materials 
Myoglobin (horse heart), insulin B chain (porcine, oxidized), angio- 
tensinogen (1 14, porcine), cyanogen bromide, and ~-cyano-4-hy- 
droxycinnamic acid were obtained from Sigma, Deisenhofen, Ger- 
many. Glucagon was purchased from Bachem, Heidelberg, Germany. 
Carboxypeptidase Y and carboxypeptidase P (EC 3.4.16.1), both se- 
quencing rade, were obtained from Boehringer-Mannheim, Germany. 
Formic acid, acetic acid, and trifluoroacetic acid, all analytical grade, 
were supplied by Merck, Darmstadt, Germany. Substance P and ovine 
corticotropin releasing factor (CRF) were synthesized automatically 
(MilliGen 9050 Peptide Synthesizer) by solid-phase methods using 
standard Fmoc chemistry . 
2.2. Carboxypeptidase digestion of substance P and CRF 
The peptide (500 pmol) was dissolved in 10/~1 sodium citrate buffer 
(50 retool/l, pH 6.0). CPY was added to give an enzyme:peptide ratio 
of 1:50 by weight. Aliquots of 1/A were taken after 1, 2, 5, 10, 15, 30 
and 60 rain incubation at ambient temperature (24°C) and mixed with 
1.5/11 of the MS matrix solution (c~-cyano-4-hydroxycinnamic acid) on 
the target for mass spectral analysis. 
2.3. Carboxypeptidase digestion of glucagon, myoglobin, 
angiotensinogen, and insulin B chain 
The peptide (500 pmol) was dissolved in 10/ll of 0.1% aqueous TFA, 
evaporated under reduced pressure and then dissolved in 10 fll of 
aqueous acetic acid at pH 5.0. CPY was added to give an en- 
zyme :peptide ratio of 1 : 50 by weight. After 10 min incubation the same 
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amount of CPP was added. Aliquots were taken and mixed with matix 
solution as described above (section 2.2). 
2.4. Cyanogen bromide digestion of myoglobin 
Myoglobin was dissolved in aqueous 70% formic acid to give a final 
concentration of 30/~M. A 200 molar excess of cyanogen bromide was 
added to 50/tl of the solution and the reaction proceeded in the dark 
for 3 h. The reaction mixture was then evaporated under reduced 
pressure. The myoglobin fragments were further digested with car- 
boxypeptidase Y and P as described in section 2.3. 
2.5. Mass spectrometry 
The mass spectra were recorded in the linear mode on a time of flight 
VG Tof Spec (Fisons, Manchester, England) or a Maldi II (Kratos, 
Manchester, England). The mass spectrometers were equipped with a 
nitrogen laser (337 nm, pulse duration 4 and 3 ns). The acceleration 
voltage was 20 kV. The spectra were obtained by summing over 50 laser 
pulses. A 50 mmol solution of c~-cyano-4-hydroxycinnamic cid in 
aqueous 50% acetonitrile and 0.1% TFA was used as the matrix. 1.5 
¢tl of the matrix and 1.0/11 of the sample were mixed on the target and 
air dried. 
3. Results 
The molecular masses of  the fragments obtained when the 
peptides were incubated with CPY and CPP are listed in Table 
1. The MALDI -MS spectra of  the CPY digestion of  substance 
P show the [M+H]  ÷ and [M+Na]  + peaks and demonstrate  that 
5 amino acids were released within 30 min. After 5 min no 
Table 1 
MALDI-MS determined masses of C-terminal truncated peptide fragments after carboxypeptidase digestion 
Sequence Mca I [M+Hl+found AM (amino acid) 
Substance P 
RPKP(~FFGLM 1347 1349 ..... 
RPKPQQFFGL 1216 1218 131 (M) 
RPKP~FFG 1103 1105 113 (L) 
RPKPQQFF 1046 1049 56 (G) 
RP~F 899 901 148 (F) 
RPK.PQQ 752 754 147 (F) 
CRF 
[ 1-35]KLLDIA 4669 4669 ..... 
[ 1-35]KLLDI 4599 4600 69(A) 
[1-35]K.LLD 4486 4488 I 12(I) 
[ 1-35]KLL 4371 . . . . . . . . . .  
[ 1-35]KL 4258 4260 228 if+D) 
Angiotensinogen [1-14] 
DRVYIHPFHLLVYS 1759 1760 ..... 
DRV YIHPFI-[LLV Y 1672 1672 88 (S) 
DRVYIHPFHLLV 1509 1509 163 (Y) 
DRV YIHPFHLL 1410 1410 99 (V) 
DR V YIHPFHL 1297 1297 113 (L) 
DRVYIHPFH 1184 1184 113 (L) 
DRVYIHPF 1047 1046 138 0"I) 
DRVYIHP 900 898 148 (F) 
DRVYIH 803 802 96 (P) 
DRVYI 667 665 137 (H) 
DRVY 55,.'1 552 113 (I) 
Glucagon 
[ 1-16IRRAQDFVQWLMN'T 3483 3483 ..... 
[ I - 16]RKAQDFVQWLMN 3382 3381 102 (T) 
[ I - 16]RRAQDFVQW'LM 3268 3267 114 (N) 
[1-16]RRAQDFVQWL 3137 3136 131 (M) 
{ 1-16]RRAQDFVQW 3024 3023 I 13 (L) 
[1-16]RRAQDFVQ 2838 2836 187 (W) 
[ I- 16]RRAQDFV 2710 2709 127 (Q) 
[1-16]RRAQDF 2607 2609 100 (V) 
I I- 16]RRAQD 2460 2461 148 (F) 
[ I - 16]RRAQ 2345 2345 116 (D) 
[ 1-16]RRA 2217 2217 128 (Q) 
[1-16]RR 2146 2148 69 (A) 
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Sequence Mca l  [M+H]+found 
Insul in B chain 
I - 19]GERG'FFYTPKA 3496 3498 ..... 
1-19]GERGFFYTPK 3425 3427 71 (A) 
1-19]GERGFFYTP 3297 3300 ! 27 (K) 
1-19]GERGFFYT 3200 3203 97 (P) 
1 - 19]GERGFFY 3099 3099 104 (T) 
1-19]GERGFF 2936 2938 161 (Y) 
1-19]GERGF 2789 2790 148 (F) 
1 -19]GERG 2642 2643 147 (F) 
1-19IGER 2585 2586 57 (G) 
I - 19]GE 2429 2430 156 (R) 
Myog lob in /CNBr -d iges l  
1-9]DIAAKYKELGFQG 2513 2516 ..... 
1-9]DIAAK YKELGFQ 2456 2459 57 (G) 
I-9]DIA.AK YKELGF 2328 2332 127 (Q) 
1-9]DIAAK YKELG 2181 2184 148 (F) 
1-9IDIAAK YKEL 2124 2126 58 (G) 
I-9]DIAAK YKE 2011 2014 I 12 (L) 
I-9]DIAAKYK 1882 1884 130 (E) 
1-9]DIAAK Y 1756 1757 127 0~) 
1-9]DIAAK 1593 1592 165 (Y) 
1-9]DIAA 1465 1464 128 (K) 
t-9]DIA 1394 1393 71 (A) 
1-9]DI 1323 1321 72 (A) 
AM (amino acid) 
substance P mass peak (1347 Da) was detected. The mass differ- 
ences, indicating the released amino acids, deviate from the 
expected masses by only 1 Da. The digestion of CRF (4669 Da) 
with CPY leads to the subsequent release of 4 amino acids 
within 10 min. However, the peptide CRF (1-38) with leucine 
in the C-terminal position was not detected. The mass accuracy 
of the detected truncated peptides was + 2 Da. 
Because of the different specificities of the serine car- 
boxypeptidases [21], a combination of CPY and CPP was used 
for sequencing of angiotensinogen, glucagon, insulin B chain 
and myoglobin. The cleavage of the first and second amino acid 
of angiotensinogen (1-14) proceeded very rapidly. Therefore, 
the first incubation was carried out for 10 min at 0°C followed 
by an incubation at ambient emperature. The masses of 10 
truncated peptides were found, with the peak intensities for 
angiotensinogen (1-5) and (1-6) being relatively weak. 
The mass spectra of the digestion of glucagon, a peptide 
containing 29 amino acids, show that after 60 min 9 amino acids 
were cleaved off (Fig. 1). The signal intensities of glucagon 
fragments 1-27 and 1-28 were weak. However, the complete 
C-terminal peptide ladder was detected with a mass accuracy 
of + 2 Da. The enzymatic digestion of the insulin B chain at 
ambient emperature (24°C) releases the C-terminal alanine 
alone after 15 min. After 60 min at 37°C it was possible 
to detect he 9 C-terminal amino acids with a mass accuracy of 
+2 Da. 
The digestion of myoglobin with CNBr generates three frag- 
ments with molecular weights of 8179 Da, 6233 Da and 2513 
Da. The treatment of this mixture with carboxypeptidases r - 
sulted in the cleavage of up to 11 amino acid residues from the 
C-terminal fragment (2513 Da) in 60 rain. The mass accuracy 
of the myoglobin fragments was determined to be _+ 3 Da. 
4. Discussion 
The results indicate that the combination of carboxypepti- 
dase digestion and MALDI-MS is an effective and convenient 
method for the analysis of the C-terminal sequence of peptides. 
MALDI-MS has some advantages over other methods of 
detection because of its speed and low sample consump- 
tion. 
Carboxypeptidases have different preferences for each amino 
acid and individual peptide bonds [21,22]. Usually, the detec- 
tion of truncated peptide of a slowly released amino acid fol- 
lowed by a rapidly released amino acid is difficult. However, 
the results how that strong peak signals with a mass accuracy 
of + 1 Da were obtained in most cases. On the other hand weak 
mass peaks with a mass accuracy of + 3 Da were also observed. 
Because of the same molecular weight of the amino acids the 
MALDI-MS is not able to differentiate between leucine/ 
isoleucine and between lysine/glutamine. In addition, at a mass 
precision of 3 Da it is impossible to distinguish between aspar- 
agine/aspartic a id, glutamine/glutamic acid/lysine, proline/val- 
ine, valine/threonine, and threonine/cysteine. Another limita- 
tion of this method is the upper limit of molecular weight which 
can be determined with necessary precision. The practical mass 
accuracy for MALDI-MS should be 0.01% [2] but for weak 
peaks the mass accuracy was only <0.1%. For this reason at 
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Fig. 1. MALDI  mass spectra of glucagon after (A) 2 min, (B) 10 min, (C) 15 min, (D) 30 min, and (E) 60 min digestion with CPY and CPP. 
masses  higher than 5000 Da  the mass  reso lut ion is not  sufficient 
for sequence analysis,  and in addit ion,  the c leavage by car- 
boxypept idase  is often hindered. For  pept ides with higher 
masses  or proteins it is better to sequence chemica l  or enzy- 
mat ic  digests, as we have shown for a cyanogen bromide diges- 
t ion o f  myog lob in .  The  use o f  a reflectron increases the accu- 
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racy in time-of-flight mass detection, but the intensity of weak 
peaks is very often lower than in the linear mode. The combined 
use of two carboxypeptidases, CPY and CPP, enabled us to 
determine serine and aspartic acid in the same time-course as 
other amino acids. Furthermore there was no slow release of 
glycine. 
The combination of carboxypeptidase hydrolysis with 
MALDI-MS is an effective tool for C-terminal sequence analy- 
sis, because MALDI-MS is a rapid and sensitive detection 
method. The easy sample preparation, the matrix which termi- 
nates the enzymatic reaction, the ability to tolerate contamina- 
tions and the easily interpretable data especially in a mixture, 
indicate that MALDI-MS has advantages in comparison with 
other mass spectrometrical methods for determination or con- 
firmation of the C-terminal sequence of polypeptides. 
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